Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis
Open Access
- 6 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica Communications
- Vol. 9 (1), 1-10
- https://doi.org/10.1186/s40478-020-01100-7
Abstract
Patients with pneumococcal meningitis are at risk for death and neurological sequelae including cognitive impairment. Functional genetic polymorphisms of macrophage migration inhibitory factor (MIF) alleles have shown to predict mortality of pneumococcal meningitis. We investigated whether MIF concentrations during the acute phase of disease were predictive for death in a nationwide prospective cohort study. Subsequently, we studied whether individual ex vivo MIF response years after meningitis was associated with the development of cognitive impairment. We found that in the acute illness of pneumococcal meningitis, higher plasma MIF concentrations were predictive for mortality (p = 0.009). Cognitive impairment, examined 1–5 years after meningitis, was present in 11 of 79 patients after pneumococcal meningitis (14%), as compared to 1 of 63 (2%) in controls, and was consistently associated with individual variability in MIF production by peripheral blood mononuclear cells after ex vivo stimulation with various infectious stimuli. Our study confirms the role of MIF in poor disease outcome of pneumococcal meningitis. Inter-individual differences in MIF production were associated with long-term cognitive impairment years after pneumococcal meningitis. The present study provides evidence that MIF mediates long-term cognitive impairment in bacterial meningitis survivors and suggests a potential role for MIF as a target of immune-modulating adjunctive therapy.Funding Information
- European Research Council (281156)
- ZonMw (016.116.358)
This publication has 38 references indexed in Scilit:
- Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe SepsisJAMA, 2010
- Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infectionCritical Care, 2009
- Seizures in adults with bacterial meningitisNeurology, 2008
- Cognitive outcome in adults after bacterial meningitisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Association between High Levels of Blood Macrophage Migration Inhibitory Factor, Inappropriate Adrenal Response, and Early Death in Patients with Severe SepsisClinical Infectious Diseases, 2007
- MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) IN MENINGOCOCCAL SEPTIC SHOCK AND EXPERIMENTAL HUMAN ENDOTOXEMIAShock, 2007
- Dexamethasone and long‐term outcome in adults with bacterial meningitisAnnals of Neurology, 2006
- Cognitive outcome in adults with moderate disability after pneumococcal meningitisJournal of Infection, 2006
- Corticoids Normalize Leukocyte Production of Macrophage Migration Inhibitory Factor in Septic ShockThe Journal of Infectious Diseases, 2005
- Glutamine synthetase, hemoglobin α-chain, and macrophage migration inhibitory factor binding to amyloid β-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer’s disease brain by immunoprecipitationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000